2022–2023 mpox outbreak in Israel
Overview of the mpox outbreak in Israel
2022–2023 mpox outbreak in Israel[edit | edit source]
The 2022–2023 mpox outbreak in Israel is part of the global 2022–2023 mpox outbreak, which saw a significant rise in cases of mpox (formerly known as monkeypox) outside of its traditional endemic regions in Africa. The outbreak in Israel began in May 2022 and has been closely monitored by health authorities.
Background[edit | edit source]
Mpox is a viral disease caused by the monkeypox virus, a member of the Orthopoxvirus genus. The disease is characterized by symptoms such as fever, headache, muscle aches, and a distinctive rash that progresses through several stages. The virus is transmitted through close contact with infected individuals or contaminated materials.
Initial Cases[edit | edit source]
The first case of mpox in Israel was reported in May 2022. The patient had recently traveled to Western Europe, where several other cases had been identified. This initial case prompted the Israeli Ministry of Health to issue alerts and guidelines to healthcare providers across the country.
Spread and Containment[edit | edit source]
Following the initial case, additional cases were identified, primarily among individuals who had traveled internationally or had close contact with confirmed cases. The Israeli government implemented measures to contain the outbreak, including contact tracing, isolation of confirmed cases, and public awareness campaigns.
Public Health Response[edit | edit source]
The Israeli Ministry of Health coordinated with international health organizations to monitor the outbreak and implement control measures. Vaccination campaigns were initiated, targeting high-risk groups, including healthcare workers and individuals with known exposure to the virus.
Impact on Public Health[edit | edit source]
The outbreak highlighted the need for robust public health infrastructure and international cooperation in managing infectious diseases. It also underscored the importance of rapid response and effective communication in preventing the spread of emerging infectious diseases.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
